Fundación Eduardo Anitua Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2011
NCT01465399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fundación Eduardo Anitua

Active Ingredients

Drugs in Phase 3 Trials (2)

platelet rich plasma (2 trials)

vitamin d (1 trial)

Drugs in Other Trials (1)

plasma rich in growth factors (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3